Phase 3 Prostate Cancer Clinical Development Lead

Pfizer; Bothell (WA); Hybrid; USD 240,000 - 400,000; Full time

Benefits offered by this job

401(k) with Pfizer matching

Health benefits

Paid vacation and holidays

Job summary

Pfizer seeks a Clinical Development Medical Director to lead a Phase 3 oncology program in prostate cancer. You will oversee medical monitoring, data interpretation, and high-quality clinical and regulatory documentation, while partnering with Clinical Operations, Safety, Regulatory, Biostatistics, Medical Writing, and other functions.

You will interact with investigators and health authorities, ensuring alignment with the overall clinical development plan and program strategy, with a strong

Qualifications

• MD/DO/MBBS/MBChB with 4+ years of experience.
• Licensed to prescribe medicines independently for 2+ years.
• Oncology clinical trial or drug development experience.
• Working knowledge of Good Clinical Practice and regulatory requirements.
• Strong written and verbal communication skills.

Responsibilities

• Provide medical and scientific leadership for a Phase 3 oncology trial in prostate cancer.
• Oversee study conduct, safety monitoring, and data interpretation.
• Contribute to study strategy, protocols, and risk-mitigation plans.
• Lead medical input for regulatory documents and scientific communications.
• Engage investigators, health authorities, and cross-functional partners.

Skills

Clinical trial design

Regulatory knowledge

Communication skills

Cross-functional collaboration

Data interpretation

Education

MD/DO/MBBS/MBChB

Job description

Pfizer seeks a Clinical Development Medical Director to lead a Phase 3 oncology program in prostate cancer. You will oversee medical monitoring, data interpretation, and high-quality clinical and regulatory documentation, while partnering with Clinical Operations, Safety, Regulatory, Biostatistics, Medical Writing, and other functions.

You will interact with investigators and health authorities, ensuring alignment with the overall clinical development plan and program strategy, with a strong